Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 17;10(2):328.
doi: 10.3390/jcm10020328.

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro

Affiliations

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro

Niko Kohmer et al. J Clin Med. .

Abstract

Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction (rRT-PCR)-based testing have been exhausted. In order to meet the demands of testing and reduce transmission, SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) are being considered. These tests are fast, inexpensive, and simple to use, but whether they detect potentially infectious cases has not been well studied. We evaluated three lateral flow assays (RIDA®QUICK SARS-CoV-2 Antigen (R-Biopharm), SARS-CoV-2 Rapid Antigen Test (Roche)), and NADAL® COVID-19 Ag Test (Nal von Minden GmbH, Regensburg, Germany) and one microfluidic immunofluorescence assay (SARS-CoV-2 Ag Test (LumiraDx GmbH, Cologne, Germany)) using 100 clinical samples. Diagnostic rRT-PCR and cell culture testing as a marker for infectivity were performed in parallel. The overall Ag-RDT sensitivity for rRT-PCR-positive samples ranged from 24.3% to 50%. However, for samples with a viral load of more than 6 log10 RNA copies/mL (22/100), typically seen in infectious individuals, Ag-RDT positivity was between 81.8% and 100%. Only 51.6% (33/64) of the rRT-PCR-positive samples were infectious in cell culture. In contrast, three Ag-RDTs demonstrated a more significant correlation with cell culture infectivity (61.8-82.4%). Our findings suggest that large-scale SARS-CoV-2 Ag-RDT-based testing can be considered for detecting potentially infective individuals and reducing the virus spread.

Keywords: Ag-RDT; PCR; POCT; SARS-CoV-2; cell culture; infectivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Antigen test analysis results for rRT-PCR-positive samples. Positive (filled data point symbols) and negative (empty data point symbols) Ag-RDT results and corresponding log10 RNA copies/mL for the ORF1 gene including mean and standard deviation bars for each test (n = 74). The dotted horizontal line in red indicates the literature-based hypothetical threshold for potential infectivity (6 log10 RNA copies/mL).
Figure 2
Figure 2
Cell culture results in correlation with the log10 RNA copies/mL of the ORF1 gene rRT-PCR reactive samples including mean and standard deviation bars (n = 64, 10 cytotoxic samples excluded).
Figure 3
Figure 3
Detection and relative quantification of SARS-CoV-2 subgenomic mRNA isoforms in infected Caco2 cells. SARS-CoV-2 sgRNA8 mRNA levels were normalized to human RNaseP.

References

    1. Mathuria J.P., Yadav R., Rajkumar Laboratory diagnosis of SARS-CoV-2—A review of current methods. J. Infect. Public Health. 2020;13:901–905. doi: 10.1016/j.jiph.2020.06.005. - DOI - PMC - PubMed
    1. Loeffelholz M.J., Tang Y.-W. Laboratory diagnosis of emerging human coronavirus infections—The state of the art. Emerg. Microbes Infect. 2020;9:747–756. doi: 10.1080/22221751.2020.1745095. - DOI - PMC - PubMed
    1. WHO WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 14 December 2020)]; Available online: https://covid19.who.int/
    1. Manabe Y.C., Sharfstein J.S., Armstrong K. The Need for More and Better Testing for COVID-19. JAMA. 2020 doi: 10.1001/jama.2020.21694. - DOI - PMC - PubMed
    1. FIND SARS-CoV-2 Diagnostic Pipeline. [(accessed on 21 December 2020)]; Available online: https://www.finddx.org/covid-19/pipeline/?avance=Commercialized&type=Rap....

LinkOut - more resources